Regulation of APC/C activators between G1/S and early anaphase
|
|
|
- ANAPC1
- ANAPC10
- ANAPC11
- ANAPC12
- ANAPC15
- ANAPC16
- ANAPC2
- ANAPC3
- ANAPC4
- ANAPC5
- ANAPC6
- ANAPC7
- ANAPC8
- APC10
- APC2
- APC4
- APC5
- APC7
- C10orf104
- C11orf51
- C9orf17
- CCN1
- CCNA
- CCNA1
- CCNA2
- CCNB
- CCNB1
- CDC16
- CDC2
- CDC20
- CDC23
- CDC26
- CDC27
- CDC28A
- CDH1
- CDK1
- CDK2
- CDKN1
- CDKN2
- CENP-27
- D0S1430E
- D17S978E
- E2EPF
- EMI1
- FBX5
- FBXO5
- FYR
- FZR
- FZR1
- KIAA1242
- KIAA1406
- P34CDC2
- SFT
- TSG24
- UBC5A
- UBCH10
- UBCH5
- UBCH5A
- UBCH6
- UBE2C
- UBE2D1
- UBE2E1
- UBE2S
|
Homo sapiens (human)
|
|
H139Hfs13* PPM1K causes a mild variant of MSUD
|
|
|
- BCATE2
- BCKDHA
- BCKDHB
- BCKDHE2
- DBT
- DLD
- GCSL
- LAD
- PHE3
- PP2CM
- PPM1K
|
Homo sapiens (human)
|
|
Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
|
|
|
- ABL
- ABL1
- ANX2
- ANX2L4
- ANXA2
- CAL1H
- CANPL2
- CAPN2
- CAPN4
- CAPNS
- CAPNS1
- CAPNS2
- CHUK
- FAK
- FAK1
- FAM38A
- FIP3
- FNRA
- FNRB
- GA11
- GAQ
- GNA11
- GNAQ
- GP3A
- IKBA
- IKBKB
- IKBKE
- IKBKG
- IKKA
- IKKB
- IKKE
- IKKI
- ITGA5
- ITGAV
- ITGB1
- ITGB3
- JTK7
- KIAA0151
- KIAA0233
- LPC2D
- MAD3
- MDF2
- MSK12
- MSK8
- NEMO
- NFKB1
- NFKB3
- NFKBI
- NFKBIA
- PIEZO1
- PPP2CA
- PPP2R1A
- PPP2R1B
- PPP2R2A
- PTK2
- PTP1B
- PTPN1
- RELA
- STAT1
- TCF16
- VCL
- VNRA
- VTNR
- YAP1
- YAP65
|
Homo sapiens (human)
|
|
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
|
|
|
- ATM
- BACH1
- BARD1
- BLM
- BRCA1
- BRCA2
- BRIP1
- C16orf75
- C7orf76
- C9orf76
- CTIP
- DNA2
- DNA2L
- DSS1
- EXO1
- EXOI
- FACD
- FANCD1
- FANCJ
- FANCN
- HEX1
- HNGS1
- HTATIP
- KAT5
- KIAA0083
- MRE11
- MRE11A
- NBN
- NBS
- NBS1
- P95
- PALB2
- PIR51
- RAD50
- RAD51
- RAD51A
- RAD51AP1
- RAD51B
- RAD51C
- RAD51D
- RAD51L1
- RAD51L2
- RAD51L3
- RBBP8
- REC2
- RECA
- RECQ2
- RECQ3
- RECQL2
- RECQL3
- RMI1
- RMI2
- RNF53
- SEM1
- SHFDG1
- SHFM1
- TIP60
- TOP3
- TOP3A
- WRN
- XRCC2
|
Homo sapiens (human)
|
|
HCN channels
|
|
|
- BCNG1
- BCNG2
- HCN1
- HCN2
- HCN3
- HCN4
- KIAA1535
|
Homo sapiens (human)
|
|
Unblocking of NMDA receptors, glutamate binding and activation
|
|
|
- ACTN2
- CALM
- CALM1
- CAM
- CAM1
- CAM2
- CAMK
- CAMK-II
- CAMK2
- CAMK2A
- CAMK2B
- CAMK2D
- CAMK2G
- CAMKA
- CAMKB
- CAMKD
- CAMKG
- DLG1
- DLG2
- DLG3
- DLG4
- GLUA1
- GLUH1
- GLUR1
- GLUR2
- GLUR3
- GLUR4
- GLURC
- GRIA1
- GRIA2
- GRIA3
- GRIA4
- GRIN1
- GRIN2A
- GRIN2B
- GRIN2C
- GRIN2D
- GluA2
- GluA3
- GluA4
- GluN2D
- KIAA0968
- KIAA1232
- KIAA1365
- LAP1
- LRRC7
- NEFL
- NF68
- NFL
- NMDAR1
- NMDAR2A
- NMDAR2B
- NMDAR2C
- NMDAR2D
- PSD95
|
Homo sapiens (human)
|
|
NFE2L2 regulating TCA cycle genes
|
|
|
- IDH1
- ME1
- NFE2L2
- NRF2
- PICD
|
Homo sapiens (human)
|
|
Activation of AMPK downstream of NMDARs
|
|
|
- AMPK
- AMPK1
- AMPK2
- AMPKG3
- CALM
- CALM1
- CAM
- CAM1
- CAMKK2
- CAMKKB
- KIAA0787
- PRKAA1
- PRKAA2
- PRKAB1
- PRKAB2
- PRKAG1
- PRKAG2
- PRKAG3
|
Homo sapiens (human)
|
|
Lysosomal oligosaccharide catabolism
|
|
|
- KIAA0935
- LAMAN
- MAN2B1
- MAN2B2
- MAN2C1
- MANA
- MANA1
- MANB
- MANB1
- MANBA
|
Homo sapiens (human)
|
|
HS-GAG degradation
|
|
|
- AGRIN
- AGRN
- ELNR1
- GLB1
- GLB1L
- GLB1L2
- GLB1L3
- GPC1
- GPC2
- GPC3
- GPC4
- GPC5
- GPC6
- GUSB
- HEP
- HPA
- HPA1
- HPA2
- HPR1
- HPSE
- HPSE1
- HPSE2
- HSE1
- HSPG1
- HSPG2
- HSS
- IDS
- IDUA
- KIAA0468
- NAGLU
- OCI5
- SDC
- SDC1
- SDC2
- SDC3
- SDC4
- SGSH
- SIDS
- UFHSD1
|
Homo sapiens (human)
|
|
N-glycan trimming in the ER and Calnexin/Calreticulin cycle
|
|
|
- AMFR
- DER1
- DERL1
- ENGASE
- G19P1
- G2AN
- GANAB
- GCS1
- HEL-220
- HEL-S-70
- KIAA0088
- KIAA0152
- MLEC
- MOGS
- NGLY1
- PNG1
- PRKCSH
- PSMC1
- RAD23B
- RNF45
- RPS27A
- SAKS1
- UBA52
- UBA80
- UBB
- UBC
- UBCEP1
- UBCEP2
- UBXN1
- VCP
|
Homo sapiens (human)
|
|
Keratan sulfate degradation
|
|
|
- ACAN
- AGC1
- CSPG1
- ELNR1
- FM
- FMOD
- GLB1
- GLB1L
- GLB1L2
- GLB1L3
- GNS
- HEXA
- HEXB
- KERA
- LDC
- LUM
- MSK16
- OGN
- OIF
- OMD
- PRELP
- SLRR2A
- SLRR2B
- SLRR2C
- SLRR2D
- SLRR2E
- SLRR3A
|
Homo sapiens (human)
|
|
Glycosphingolipid catabolism
|
|
|
- ARSA
- ARSB
- ARSC1
- ARSD
- ARSE
- ARSF
- ARSG
- ARSH
- ARSI
- ARSJ
- ARSK
- ARSL
- ASAH
- ASAH1
- ASAH2
- ASM
- CBG
- CBGL1
- CTSA
- ELNR1
- ENPP7
- GALC
- GBA
- GBA1
- GBA2
- GBA3
- GC
- GLA
- GLB1
- GLB1L
- GLB1L2
- GLB1L3
- GLBA
- GLUC
- GM2A
- HEXA
- HEXB
- HNAC1
- KIAA1001
- KIAA1418
- KIAA1605
- M6PR
- MPR46
- MPRD
- NANH
- NEU1
- NEU2
- NEU3
- PPGB
- PSAP
- SAP1
- SKNY
- SMPD1
- SMPD2
- SMPD3
- SMPD4
- SPG46
- STS
- SUMF1
- SUMF2
- TSULF
|
Homo sapiens (human)
|
|
Defective HEXA causes GM2G1
|
|
|
|
Homo sapiens (human)
|
|
Defective HEXB causes GM2G2
|
|
|
|
Homo sapiens (human)
|
|
Scavenging by Class A Receptors
|
|
|
- APOA1
- APOB
- APOE
- CALR
- CLP1
- COL1A1
- COL1A2
- COL3A1
- COL4A1
- COL4A2
- COLEC11
- COLEC12
- CRARF
- CRARF1
- CRTC
- FTH
- FTH1
- FTHL6
- FTL
- GRP94
- HSP90B1
- HSPC4
- MARCO
- MASP1
- MSR1
- NSR2
- PNSP1
- PRSS5
- SCARA1
- SCARA2
- SCARA4
- SCARA5
- SCGB3A2
- SRCL
- TRA1
- UGRP1
|
Homo sapiens (human)
|
|
CS/DS degradation
|
|
|
- ARSB
- BCAN
- BEHAB
- BGN
- CALEB
- CSPG2
- CSPG3
- CSPG4
- CSPG5
- CSPG7
- DCN
- HEXA
- HEXB
- HYAL1
- HYAL3
- IDS
- IDUA
- LUCA1
- LUCA3
- MCSP
- NCAN
- NEUR
- NGC
- SIDS
- SLRR1A
- SLRR1B
- VCAN
|
Homo sapiens (human)
|
|
Pentose phosphate pathway
|
|
|
- CARKL
- DERA
- G6PD
- PGD
- PGDH
- PGLS
- PGM2
- RBKS
- RBSK
- RPE
- RPEL1
- RPI
- RPIA
- SHPK
- TAL
- TALDO
- TALDO1
- TALDOR
- TKT
|
Homo sapiens (human)
|
|
MPS IX - Natowicz syndrome
|
|
|
|
Homo sapiens (human)
|
|
MPS VII - Sly syndrome
|
|
|
|
Homo sapiens (human)
|
|
Hyaluronan uptake and degradation
|
|
|
- APNH1
- CD44
- CHP
- CHP1
- CRSBP1
- FEEL2
- FELL
- FEX2
- GUSB
- HAR
- HARE
- HEXA
- HEXB
- HMMR
- HYAL1
- HYAL2
- HYAL3
- IHABP
- LHR
- LUCA1
- LUCA2
- LUCA3
- LYVE1
- MDU2
- MDU3
- MIC4
- NHE1
- RHAMM
- SLC9A1
- STAB2
- XLKD1
|
Homo sapiens (human)
|
|
Hyaluronan biosynthesis and export
|
|
|
- ABCC5
- CEMIP
- HAS
- HAS1
- HAS2
- HAS3
- HYBID
- KIAA1199
- MRP5
|
Homo sapiens (human)
|
|
Lewis blood group biosynthesis
|
- 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3
- 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9
- 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5
- 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6
- Alpha-(1,3)-fucosyltransferase 10
- Alpha-(1,3)-fucosyltransferase 11
- Alpha-(1,3)-fucosyltransferase 4
- Alpha-(1,3)-fucosyltransferase 7
- Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
- Beta-1,3-galactosyltransferase 1
- Beta-1,3-galactosyltransferase 2
- Beta-1,3-galactosyltransferase 4
- Beta-1,3-galactosyltransferase 5
- Beta-1,4 N-acetylgalactosaminyltransferase 2
- CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase
- CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4
- Galactoside alpha-(1,2)-fucosyltransferase 2
- Type 2 lactosamine alpha-2,3-sialyltransferase
|
|
- B3GALT1
- B3GALT2
- B3GALT4
- B3GALT5
- B4GALNT2
- CGS23
- ELFT
- FCT3A
- FT3B
- FUT10
- FUT11
- FUT2
- FUT3
- FUT4
- FUT5
- FUT6
- FUT7
- FUT9
- GALGT2
- GALT4
- LE
- NANTA3
- SEC2
- SIAT10
- SIAT4C
- SIAT6
- SIAT7F
- ST3GAL3
- ST3GAL4
- ST3GAL6
- ST6GALNAC6
- STZ
|
Homo sapiens (human)
|
|
Alkylating DNA damage induced by chemotherapeutic drugs
|
|
|
|
Homo sapiens (human)
|
|
Reversible DNA damage induced by alkylating chemotherapeutic drugs
|
|
|
|
Homo sapiens (human)
|
|